The effect of 8 weeks of treatment with transcranial pulsed electromagnetic fields on hand tremor and inter-hand coherence in persons with Parkinson's disease

Anne Sofie Bøgh Malling, Bo Mohr Morberg, Lene Wermuth, Ole Gredal, Per Bech, Bente Rona Jensen, Anne Sofie Bøgh Malling, Bo Mohr Morberg, Lene Wermuth, Ole Gredal, Per Bech, Bente Rona Jensen

Abstract

Background: Parkinson's disease (PD) tremor comprises asymmetric rest and postural tremor with unilateral onset. Tremor intensity can be amplified by stress and reduced by attention, and the medical treatment is complex. Mirror movements and unintentional synchronization of bimanual movements, possibly caused by insufficient inhibition of inter-hemispheric crosstalk, have been reported in PD, indicating a lag of lateralization. Potential neuroprotective effects of pulsed electromagnetic fields (PEMF) have been reported in-vitro and in rodents, as have influences of PEMF on human tremor. The aim was to investigate the effect of 8 weeks daily transcranial PEMF treatment (T-PEMF) of persons with PD on rest and postural hand tremor characteristics and on inter-hand coherence.

Methods: Hand accelerations of 50 PD participants with uni- or bilateral tremor participating in a clinical trial were analysed. A rest and postural tremor task performed during serial subtraction was assessed before and after 8 weeks of T-PEMF (30 min/day, 50 Hz, ±50 V, 3 ms squared pulses) or placebo treatment (sham stimulation 30 min/day). Forty matched healthy persons (no treatment) were included as reference. Intensity and inter-hand coherence related measures were extracted.

Results: The T-PEMF treatment decreased the inter-hand coherence in the PD group with unilateral postural tremor. The PD group with unilateral postural tremor was less clinically affected by the disease than the PD group with bilateral postural tremor. However, no differences between T-PEMF and placebo treatment on either intensity related or coherence related measures were found when all persons with PD were included in the analyses. The peak power decreased and the tremor intensity tended to decrease in both treatment groups.

Conclusions: Eight weeks of T-PEMF treatment decreased inter-hand coherence in the PD group with unilateral postural tremor, while no effects of T-PEMF treatment were found for the entire PD group. The unilateral postural tremor group was less clinically affected than the bilateral postural tremor group, suggesting that early treatment initiation may be beneficial. In theory, a reduced inter-hand coherence could result from a neuronal treatment response increasing inter-hemispheric inhibition. However, this requires further studies to determine. Studies of even longer treatment periods would be of interest.

Trial registration: ClinicalTrials.gov , NCT02125032. Registered 29 April 2014, https://ichgcp.net/clinical-trials-registry/NCT02125032?term=NCT02125032&rank=1.

Keywords: Accelerometry; Inter-hand coherence; PEMF; Parkinson’s disease; Postural tremor; Rest tremor; T-PEMF; Tremor intensity.

Conflict of interest statement

Ethics approval and consent to participate

The study was approved by the Regional Scientific Ethical Committees for Southern Denmark (S-20130114) and the Danish Health Authority (CIV-14-01-011780), and was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent prior to participation.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Treatment effect on intensity related measures for the rest and postural condition, measured values. A and D Tremor intensity (TI). B and E Peak power (Powpeak). C and F Peak power (Freqpeak). T-PEMF = transcranial pulsed electromagnetic fields. REF = healthy reference group. * = significant difference from week 0 to week 8 across treatment groups (P ≤ 0.05). (*) = tendency of difference from week 0 to week 8 across treatment groups (0.05 < P ≤ 0.1). # = significant difference between the treatment groups combined at week 0 and REF (P ≤ 0.05)
Fig. 2
Fig. 2
Treatment effect on inter-hand coherence measures for the rest and postural condition, measured values. A and D Coherence (Coh). B and E Peak coherence (Cohpeak). C and F Frequency of peak coherence (Cohfreq). T-PEMF = transcranial pulsed electromagnetic fields. REF = healthy reference group. * = significant difference from week 0 to week 8 across treatment groups (P ≤ 0.05). # = significant difference between the treatment groups combined at week 0 and REF (P ≤ 0.05). (#) = tendency of difference between the treatment groups combined at week 0 and REF (0.05 < P ≤ 0.1)

References

    1. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30:1591–1601.
    1. Gigante AF, Pellicciari R, Iliceto G, Liuzzi D, Mancino PV, Custodero GE, Guido M, Livrea P, Defazio G. Rest tremor in Parkinson’s disease: body distribution and time of appearance. J Neurol Sci. 2017;375:215–219.
    1. Liu K, Gu Z, Dong L, Shen L, Sun Y, Zhang T, Shi N, Zhang Q, Zhang W, Zhao M, Sun X. Clinical profile of Parkinson's disease in the Gumei community of Minhang district, Shanghai. Clinics (Sao Paulo) 2014;69:457–463.
    1. Belvisi D, Conte A, Bologna M, Bloise MC, Suppa A, Formica A, Costanzo M, Cardone P, Fabbrini G, Berardelli A. Re-emergent tremor in Parkinson’s disease. Parkinsonism Relat Disord. 2017;36:41–46.
    1. Ayturk Z, Yilmaz R, Akbostanci MC. Re-emergent tremor in Parkinson’s disease: clinical and accelerometric properties. J Clin Neurosci. 2017;37:31–33.
    1. Mailankody P, Thennarasu K, Nagaraju BC, Yadav R, Pal PK. Re-emergent tremor in Parkinson’s disease: a clinical and electromyographic study. J Neurol Sci. 2016;366:33–36.
    1. Zach H, Dirkx M, Bloem BR, Helmich RC. The clinical evaluation of Parkinson's tremor. J Parkinsons Dis. 2015;5:471–474.
    1. Lee HJ, Lee WW, Kim SK, Park H, Jeon HS, Kim HB, Jeon BS, Park KS. Tremor frequency characteristics in Parkinson's disease under resting-state and stress-state conditions. J Neurol Sci. 2016;362:272–277.
    1. Zach H, Dirkx MF, Pasman JW, Bloem BR, Helmich RC. Cognitive stress reduces the effect of levodopa on Parkinson's resting tremor. CNS Neurosci Ther. 2017;23:209–215.
    1. Fishman PS. Paradoxical aspects of parkinsonian tremor. Mov Disord. 2008;23:168–173.
    1. Cox BC, Cincotta M, Espay AJ. Mirror movements in movement disorders. Tremor Other Hyperkinet Mov. 2012;2. .
    1. van Wijk BC, Beek PJ, Daffertshofer A. Neural synchrony within the motor system: what have we learned so far? Front Hum Neurosci. 2012;6:252.
    1. Chatterjee P, Banerjee R, Choudhury S, Mondal B, Kulsum MU, Chatterjee K, Kumar H. Mirror movements in Parkinson’s disease: an under-appreciated clinical sign. J Neurol Sci. 2016;366:171–176.
    1. van den Berg C, Beek PJ, Wagenaar RC, van Wieringen PC. Coordination disorders in patients with Parkinson’s disease: a study of paced rhythmic forearm movements. Exp Brain Res. 2000;134:174–186.
    1. Byblow WD, Summers JJ, Lewis GN, Thomas J. Bimanual coordination in Parkinson's disease: deficits in movement frequency, amplitude, and pattern switching. Mov Disord. 2002;17:20–29.
    1. Johnson KA, Cunnington R, Bradshaw JL, Phillips JG, Iansek R, Rogers MA. Bimanual co-ordination in Parkinson's disease. Brain. 1998;121(Pt 4):743–753.
    1. Disbrow EA, Sigvardt KA, Franz EA, Turner RS, Russo KA, Hinkley LB, Herron TJ, Ventura MI, Zhang L, Malhado-Chang N. Movement activation and inhibition in Parkinson's disease: a functional imaging study. J Parkinsons Dis. 2013;3:181–192.
    1. Hei WH, Byun SH, Kim JS, Kim S, Seo YK, Park JC, Kim SM, Jahng JW, Lee JH. Effects of electromagnetic field (PEMF) exposure at different frequency and duration on the peripheral nerve regeneration: in vitro and in vivo study. Int J Neurosci. 2016;126:739–748.
    1. Urnukhsaikhan E, Cho H, Mishig-Ochir T, Seo YK, Park JK. Pulsed electromagnetic fields promote survival and neuronal differentiation of human BM-MSCs. Life Sci. 2016;151:130–138.
    1. Zhang Y, Ding J, Duan W. A study of the effects of flux density and frequency of pulsed electromagnetic field on neurite outgrowth in PC12 cells. J Biol Phys. 2006;32:1–9.
    1. Longo FM, Yang T, Hamilton S, Hyde JF, Walker J, Jennes L, Stach R, Sisken BF. Electromagnetic fields influence NGF activity and levels following sciatic nerve transection. JNeurosciRes. 1999;55:230–237.
    1. Tepper OM, Callaghan MJ, Chang EI, Galiano RD, Bhatt KA, Baharestani S, Gan J, Simon B, Hopper RA, Levine JP, Gurtner GC. Electromagnetic fields increase in vitro and in vivo angiogenesis through endothelial release of FGF-2. FASEB J. 2004;18:1231–1233.
    1. Bragin DE, Statom GL, Hagberg S, Nemoto EM. Increases in microvascular perfusion and tissue oxygenation via pulsed electromagnetic fields in the healthy rat brain. J Neurosurg. 2015;122:1239–1247.
    1. Cuccurazzu B, Leone L, Podda MV, Piacentini R, Riccardi E, Ripoli C, Azzena GB, Grassi C. Exposure to extremely low-frequency (50 Hz) electromagnetic fields enhances adult hippocampal neurogenesis in C57BL/6 mice. Exp Neurol. 2010;226:173–182.
    1. Arias-Carrion O, Verdugo-Diaz L, Feria-Velasco A, Millan-Aldaco D, Gutierrez AA, Hernandez-Cruz A, Drucker-Colin R. Neurogenesis in the subventricular zone following transcranial magnetic field stimulation and nigrostriatal lesions. J Neurosci Res. 2004;78:16–28.
    1. Di Lazzaro V, Capone F, Apollonio F, Borea PA, Cadossi R, Fassina L, Grassi C, Liberti M, Paffi A, Parazzini M, et al. A consensus panel review of central nervous system effects of the exposure to low-intensity extremely low-frequency magnetic fields. Brain Stimul. 2013;6:469–476.
    1. Malling ASB, Morberg BM, Wermuth L, Gredal O, Bech P, Jensen BR. Effect of transcranial pulsed electromagnetic fields (T-PEMF) on functional rate of force development and movement speed in persons with Parkinson's disease: a randomized clinical trial. PLoS One. 2018;13:e0204478.
    1. Sandyk R. Weak magnetic fields in the treatment of Parkinson’s disease with the “on-off” phenomenon. Int J Neurosci. 1992;66:97–106.
    1. Legros A, Beuter A. Effect of a low intensity magnetic field on human motor behavior. Bioelectromagnetics. 2005;26:657–669.
    1. Morberg BM, Malling AS, Jensen BR, Gredal O, Bech P, Wermuth L. Parkinson's disease and transcranial pulsed electromagnetic fields: a randomized clinical trial. Mov Disord. 2017;32:625–626.
    1. Morberg BM, Malling AS, Jensen BR, Gredal O, Bech P, Wermuth L. Effects of transcranial pulsed electromagnetic field stimulation on quality of life in Parkinson's disease. Eur J Neurol. 2018;25:963–e974.
    1. Fahn S, Elton RL, Committee. MotUD: Unified Parkinson's Disease Rating Scale. In Recent development in Parkinson's disease. Volume 2. Edited by Fahn S, Marsden CD, Calne DB, Goldstein M. Florham Park, NJ: Macmillan Health Care Information; 1987: 153–164.
    1. Spedden ME, Malling ASB, Andersen KK, Jensen BR. Association between gross-motor and executive function depends on age and motor task complexity. Dev Neuropsychol. 2017;42:495–506.
    1. Rahbek UL, Tritsaris K, Dissing S. Interaction of low-frequency, pulsed electromagnetic fields with living tissue: biochemical responses and clinical results. Oral Bioscience Med. 2005;2:1–12.
    1. Terry K, Griffin L. How computational technique and spike train properties affect coherence detection. J Neurosci Methods. 2008;168:212–223.
    1. Terry K, Griffin L. Corrigendum to “how computational technique and spike train properties affect coherence detection” [J. Neurosci. Methods 168 (2008) 212–223] J Neurosci Methods. 2008;171:180.
    1. Hsieh TH, Huang YZ, Rotenberg A, Pascual-Leone A, Chiang YH, Wang JY, Chen JJ. Functional dopaminergic neurons in substantia Nigra are required for transcranial magnetic stimulation-induced motor plasticity. Cereb Cortex. 2015;25:1806–1814.
    1. Barbagallo G, Nistico R, Vescio B, Cerasa A, Olivadese G, Nigro S, Crasa M, Quattrone A, Bianco MG, Morelli M, et al. The placebo effect on resting tremor in Parkinson's disease: an electrophysiological study. Parkinsonism Relat Disord. 2018.
    1. Morrison S, Newell KM, Kavanagh JJ. Differences in postural tremor dynamics with age and neurological disease. Exp Brain Res. 2017;235:1719–1729.
    1. Hurtado JM, Lachaux JP, Beckley DJ, Gray CM, Sigvardt KA. Inter- and intralimb oscillator coupling in parkinsonian tremor. Mov Disord. 2000;15:683–691.
    1. Cruz-Montecinos C, Calatayud J, Iturriaga C, Bustos C, Mena B, Espana-Romero V, Carpes FP. Influence of a self-regulated cognitive dual task on time to failure and complexity of submaximal isometric force control. Eur J Appl Physiol. 2018.
    1. Serrien DJ. Verbal-manual interactions during dual task performance: an EEG study. Neuropsychologia. 2009;47:139–144.
    1. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord. 2010;25:2649–2653.

Source: PubMed

3
Subscribe